What's New at CBER 06/13/2023 U.S. Food and Drug Administration sent this bulletin at 06/13/2023 04:36 PM EDT What's New at CBER You are subscribed to What's New at CBER for the U.S. Food & Drug Administration (FDA) What's New Today The following links have been updated recently: Posted: 06/13/2023 June 9, 2023 Clinical Review - AFSTYLA June 9, 2023 Statistical Review - AFSTYLA CBER Cures Vacancy Announcement - Physician, AD-0602-Band C, Office of Vaccines Research and Review (OVRR), Division of Vaccines and Related Product Applications (DVRPA) CBER Cures Vacancy Announcement - Branch Chief, AD-0602-Band D, Office of Therapeutic Products (OTP), Oncology Branch 2 (OB2) CBER Vacancy: Principal Investigator: Molecular Biologist with Bioinformatics experience BK220668 - VorFat System Upcoming CBER Workshop/Meetings/Town Halls June Vaccines and Related Biological Products Advisory Committee Meeting June 15, 2023 AnnouncementJune 15, 2023 Virtual Meeting: Decentralized Clinical Trials (DCT) Draft Guidance June 20, 2023 FDA Drug Topics: Biosimilars: A Review of Scientific, Regulatory, and Clinical Considerations for Health Care Providers June 20, 2023 November Electronic Submission of Adverse Event Reports to FDA Adverse Event Reporting System (FAERS) using International Council for Harmonisation (ICH) E2B(R3) StandardsNovember 7, 2023
